RecruitingNot ApplicableNCT06789692

Reduce Tobacco Use in People Living With HIV in Switzerland

Reduce Tobacco Use in People Living With HIV in Switzerland: A Pragmatic Randomized Trial Within the Swiss HIV Cohort Study


Sponsor

University Hospital, Basel, Switzerland

Enrollment

972 participants

Start Date

Feb 20, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this trial is to test the effectiveness of offering a menu of different tobacco smoking substitutional products (e-cigarettes, nicotine pouches, nicotine patches in addition to usual of care) for smokers in the SHCS (Swiss HIV Cohort Study) in achieving self-reported 7-day tobacco cigarette abstinence at 6 months.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a tobacco cessation intervention (a program to help people quit smoking) for people living with HIV in Switzerland. HIV-positive individuals have higher rates of smoking and face increased health risks from it, so this study aims to identify what helps them quit. **You may be eligible if...** - You are 18 years or older - You are living with HIV and enrolled in the Swiss HIV Cohort Study - You have agreed to be randomized in future intervention studies - You currently smoke at least one cigarette per day **You may NOT be eligible if...** - You are currently using e-cigarettes, nicotine pouches, or nicotine patches - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERtobacco smoking substitution products

Offer of preference-based smoking substitution menu, consisting of e-cigarettes or nicotine pouches or nicotine patches in addition to standard of care. This menu will be offered by the treating physician during the routine cohort visit and the participant can choose one product to test as an alternative to tobacco smoking. The products will be handed out directly after the consultation and are provided free of charge for 6 months.


Locations(7)

Cantonal Hospital St. Gallen

Sankt Gallen, Canton of St. Gallen, Switzerland

University Hospital Lausanne

Lausanne, Canton of Vaud, Switzerland

Cantonal Hospital Aarau

Aarau, Switzerland

University Hospital Basel

Basel, Switzerland

Inselspital Bern

Bern, Switzerland

University Hospital Geneva

Geneva, Switzerland

University Hospital Zurich

Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06789692


Related Trials